Competitors of Gujarat Terce Laboratories Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,399 Cr. | 312 | 390/108 | 64.5 | 20.5 | 0.21 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 58.6 Cr. | 79.0 | 94.9/25.8 | 22.5 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 28.0 Cr. | 19.1 | 19.5/8.35 | 36.3 | 6.64 | 0.00 % | 4.06 % | 3.33 % | 10.0 |
| Godavari Drugs Ltd | 86.2 Cr. | 114 | 155/87.0 | 12.9 | 55.4 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 12,800 Cr. | 1,046 | 1,335/620 | 30.2 | 207 | 2.15 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 437 Cr. | 19.2 | 29.0/13.2 | 25.3 | 7.68 | 0.00 % | 14.4 % | 10.4 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.25 Cr. | 15.0 | 28.5/13.1 | 145 | 13.4 | 0.00 % | 3.19 % | 0.84 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 317 Cr. | 674 | 1,054/650 | 17.9 | 278 | 0.10 % | 17.6 % | 15.0 % | 10.0 |
| Fervent Synergies Ltd | 52.0 Cr. | 17.3 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 960 Cr. | 326 | 355/145 | 117 | 98.6 | 0.38 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 5.88 Cr. | 28.0 | 43.8/23.6 | 118 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 18.2 Cr. | 7.31 | 19.4/7.21 | 40.4 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 108 Cr. | 136 | 184/110 | 50.6 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 128 Cr. | 1.84 | 3.10/0.98 | 173 | 3.80 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 16.5 Cr. | 6.87 | 14.5/6.40 | 15.2 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.2 Cr. | 15.1 | 25.8/14.4 | 18.4 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 278 Cr. | 780 | 999/345 | 12.0 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 36.0 Cr. | 36.0 | 61.5/30.6 | 33.9 | 0.00 % | 4.50 % | 1.29 % | 10.0 | |
| Colinz Laboratories Ltd | 25.2 Cr. | 55.0 | 84.4/36.0 | 45.7 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 11.8 Cr. | 4.72 | 26.5/4.12 | 47.2 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 12.3 Cr. | 82.1 | 94.7/40.4 | 9.86 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.11 Cr. | 13.0 | 17.4/4.09 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 52.1 Cr. | 69.0 | 160/63.0 | 33.0 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.23 Cr. | 20.8 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 102 Cr. | 23.6 | 43.9/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 16.6 Cr. | 32.8 | 46.0/20.2 | 48.8 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 198 Cr. | 344 | 408/175 | 20.4 | 110 | 1.31 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 25.6 Cr. | 43.4 | 50.0/4.68 | 65.6 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 71,690 Cr. | 1,224 | 1,593/958 | 19.7 | 527 | 0.37 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 124 Cr. | 200 | 307/112 | 20.2 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 977 Cr. | 195 | 265/140 | 16.6 | 60.5 | 1.28 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 60.1 Cr. | 46.0 | 86.1/43.5 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 8,524 Cr. | 2,081 | 2,185/1,004 | 91.3 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 6.34 Cr. | 0.96 | 1.20/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 422 Cr. | 55.1 | 77.7/37.5 | 31.7 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 14.6 Cr. | 25.0 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 114 Cr. | 68.0 | 82.5/40.2 | 173 | 18.5 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 58,836 Cr. | 27,718 | 30,521/21,983 | 45.8 | 1,657 | 1.48 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,913 Cr. | 653 | 722/381 | 25.9 | 205 | 0.46 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 156 Cr. | 56.3 | 75.8/37.0 | 22.6 | 46.6 | 0.00 % | 6.18 % | 3.81 % | 10.0 |
| Zota Health Care Ltd | 1,547 Cr. | 564 | 725/400 | 58.0 | 0.18 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 20,080 Cr. | 1,233 | 1,335/323 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 734 Cr. | 221 | 291/98.4 | 26.6 | 11.8 | 0.00 % | 62.5 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 11.0 % | 268 % | 2.00 | |
| Venus Remedies Ltd | 388 Cr. | 292 | 430/280 | 17.6 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 6,040 Cr. | 858 | 950/401 | 121 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,119 Cr. | 1,497 | 1,923/1,232 | 32.8 | 735 | 0.67 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,07,094 Cr. | 3,167 | 3,591/2,025 | 61.5 | 222 | 0.88 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,665 Cr. | 289 | 317/154 | 50.3 | 44.8 | 0.17 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,838 Cr. | 19.5 | 27.9/10.5 | 57.8 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 32,922 Cr. | 1,295 | 1,359/585 | 136 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,560 Cr. | 117 | 169/74.5 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,31,322 Cr. | 1,795 | 1,960/1,184 | 38.5 | 288 | 0.75 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,455 Cr. | 799 | 851/292 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,038 Cr. | 241 | 398/113 | 34.7 | 70.6 | 0.17 % | 11.4 % | 9.53 % | 1.00 |
| SMS Lifesciences India Ltd | 315 Cr. | 1,008 | 1,750/487 | 15.5 | 621 | 0.15 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 8,928 Cr. | 913 | 960/313 | 155 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 5,057 Cr. | 202 | 241/91.8 | 238 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 13,932 Cr. | 6,054 | 7,600/4,606 | 33.0 | 298 | 2.76 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,290 Cr. | 1,992 | 2,977/1,290 | 37.8 | 229 | 0.80 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,450 Cr. | 5,095 | 5,836/4,637 | 37.3 | 324 | 1.18 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 256 Cr. | 72.6 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 23,916 Cr. | 5,226 | 6,453/3,950 | 39.1 | 820 | 0.67 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 362 Cr. | 294 | 325/190 | 19.8 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,507 Cr. | 410 | 420/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 7,420 Cr. | 1,458 | 1,592/557 | 62.4 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 19,090 Cr. | 14,905 | 16,561/4,926 | 72.3 | 1,087 | 0.09 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 755 Cr. | 33.6 | 56.5/26.2 | 70.4 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,320 Cr. | 1,358 | 1,639/752 | 12.5 | 399 | 0.70 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,052 Cr. | 73.9 | 101/38.6 | 30.9 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,994 Cr. | 309 | 329/126 | 40.4 | 50.3 | 0.19 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 165 Cr. | 105 | 145/85.2 | 17.5 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 512 Cr. | 143 | 173/97.9 | 162 | 27.7 | 0.00 % | 3.95 % | 6.61 % | 10.0 |
| Lupin Ltd | 94,480 Cr. | 2,071 | 2,312/1,200 | 36.0 | 343 | 0.39 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,237 Cr. | 618 | 814/498 | 12.8 | 319 | 0.29 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 27,643 Cr. | 513 | 518/359 | 118 | 79.2 | 0.16 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 895 Cr. | 863 | 961/356 | 26.0 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 177 Cr. | 82.3 | 122/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,058 Cr. | 220 | 370/198 | 20.0 | 103 | 1.37 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 495 Cr. | 310 | 470/298 | 35.2 | 118 | 0.00 % | 12.8 % | 7.83 % | 10.0 |
| Jubilant Pharmova Ltd | 18,128 Cr. | 1,138 | 1,310/409 | 63.7 | 373 | 0.44 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,873 Cr. | 1,743 | 2,030/1,371 | 44.0 | 207 | 0.70 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,694 Cr. | 638 | 655/270 | 63.3 | 74.4 | 0.78 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 40,382 Cr. | 1,591 | 1,709/1,041 | 64.8 | 264 | 0.25 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,047 Cr. | 348 | 538/331 | 20.4 | 283 | 1.44 % | 12.3 % | 8.68 % | 10.0 |
| Indoco Remedies Ltd | 2,950 Cr. | 320 | 417/286 | 132 | 118 | 0.47 % | 10.4 % | 8.33 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 41,744 Cr. | 1,478 | 1,831/764 | 299 | 0.17 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 40,831 Cr. | 2,412 | 3,088/1,616 | 50.9 | 98.7 | 1.33 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 1,01,400 Cr. | 1,214 | 1,421/1,074 | 19.0 | 369 | 0.66 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,588 Cr. | 228 | 283/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,20,037 Cr. | 1,486 | 1,702/1,178 | 26.1 | 351 | 0.87 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,921 Cr. | 1,964 | 2,177/1,178 | 30.2 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 367 Cr. | 140 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,386 Cr. | 132 | 150/92.2 | 15.7 | 96.0 | 0.38 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 96.3 Cr. | 59.2 | 92.0/42.6 | 182 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 39,800 Cr. | 332 | 396/231 | 27.6 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 2,004 Cr. | 2,085 | 2,326/1,060 | 48.9 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 218 Cr. | 137 | 158/89.0 | 28.6 | 43.2 | 0.87 % | 12.1 % | 11.1 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 189 Cr. | 80.0 | 113/73.2 | 246 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 15,800 Cr. | 6,320 | 8,140/4,050 | 123 | 272 | 0.38 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,023 Cr. | 700 | 863/556 | 42.6 | 103 | 0.66 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 233 Cr. | 111 | 145/69.9 | 11.2 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 66,778 Cr. | 5,583 | 6,440/4,407 | 30.7 | 961 | 0.72 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,479 Cr. | 1,042 | 1,304/710 | 32.2 | 249 | 1.06 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 725 Cr. | 1,269 | 1,754/911 | 10.6 | 724 | 0.91 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 36,975 Cr. | 2,960 | 3,486/1,850 | 42.3 | 294 | 1.22 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 4,097 Cr. | 366 | 571/322 | 27.9 | 120 | 1.39 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,130 Cr. | 449 | 635/430 | 33.0 | 126 | 0.22 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,451.65 Cr | 1,190.01 | 55.13 | 184.88 | 0.32% | 16.40% | 16.92% | 6.61 |
